Michael Scolaro

Michael Scolaro

Oct 20, 2017

Group 6 Copy 16
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

    The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

    One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

    Backer Badge Funded